Source: Zacks

Utah Medical Products: Utah Medical's EPS Declines 27% Y/Y in Q4, Stock Drops 5%

UTMD's Q4 EPS drops 27.4% year over year, and revenues fall 25.8% on weak PendoTECH sales. Revenues are expected to decline further in 2025.

Read full article »
Utah Medical Products's Competitors | Utah Medical Products's News | Utah Medical Products's Financials
Stay up-to-date with the latest news on Utah Medical Products
Annual Revenue
$25-100M
Employees
100-250
Kevin L. Cornwell's photo - Chairman & CEO of Utah Medical Products

Chairman & CEO

Kevin L. Cornwell

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Utah Medical Products